WP
EWTX icon

Woodline Partners’s Edgewise Therapeutics EWTX Stock Holding History

Woodline Partners’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.11M Hold
224,290
– – 0.03% 558
2026
Q1 		$7.07M Buy
224,290
+98
+0% +$2.83K 0.03% 591
2025
Q4 		$5.56M Buy
224,192
+2
+0% +$40 0.02% 605
2025
Q3 		$3.64M Sell
224,190
-872,673
-80% -$12.4M 0.02% 627
2025
Q2 		$14.4M Buy
1,096,863
+54
+0% +$779 0.08% 356
2025
Q1 		$24.1M Buy
1,096,809
+529,591
+93% +$13.9M 0.16% 190
2024
Q4 		$15.1M Buy
567,218
+39,379
+7% +$1.25M 0.1% 265
2024
Q3 		$14.1M Buy
527,839
+106,235
+25% +$2.11M 0.12% 240
2024
Q2 		$7.59M Buy
421,604
+16,472
+4% +$287K 0.07% 286
2024
Q1 		$7.39M Buy
405,132
+920
+0.2% +$14.6K 0.07% 313
2023
Q4 		$4.42M Buy
404,212
+44,119
+12% +$310K 0.05% 330
2023
Q3 		$2.06M Hold
360,093
– – 0.02% 398
2023
Q2 		$2.79M Hold
360,093
– – 0.03% 385
2023
Q1 		$2.4M Buy
360,093
+2
+0% +$19 0.03% 398
2022
Q4 		$3.22M Sell
360,091
-179,773
-33% -$1.69M 0.04% 386
2022
Q3 		$5.31M Sell
539,864
-231,933
-30% -$2.34M 0.07% 279
2022
Q2 		$6.14M Buy
771,797
+411,704
+114% +$3.11M 0.09% 230
2022
Q1 		$3.49M Sell
360,093
-42,756
-11% -$550K 0.06% 289
2021
Q4 		$6.16M Buy
402,849
+41,028
+11% +$738K 0.09% 259
2021
Q3 		$6.01M Buy
361,821
+7,332
+2% +$133K 0.1% 228
2021
Q2 		$7.56M Sell
354,489
-2,940
-0.8% -$80.4K 0.14% 174
2021
Q1 		$11.6M Buy
+357,429
New +$11.6M 0.26% 100

Other funds holding EWTX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Woodline Partners's EWTX Position: Q2 2026 in Review

Woodline Partners held its Edgewise Therapeutics (EWTX) position steady in Q2 2026 at 224,290 shares worth $9.11M. The position accounts for 0.03% of the portfolio, ranked #558.

Woodline Partners first reported a position in EWTX in Q1 2021 and has held it in 22 quarters since. The position peaked at $24.1M in Q1 2025. 226 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • Woodline Partners held 224,290 shares of Edgewise Therapeutics worth $9.11M as of Q2 2026.
  • Woodline Partners left its Edgewise Therapeutics share count unchanged in Q2 2026.
  • Edgewise Therapeutics made up 0.03% of Woodline Partners's portfolio in Q2 2026, its #558 holding.
  • Woodline Partners first reported a position in Edgewise Therapeutics in Q1 2021 and has held it in 22 quarters since.
  • Woodline Partners's Edgewise Therapeutics position peaked at $24.1M in Q1 2025.
  • 226 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.